Fucoidan

Integrative Medicine
Developing Your Personal Care Plan
Integrative Medicine at Home Membership Program
Therapies, Classes & Workshops
About Herbs, Botanicals & Other Products
About Mind-Body Therapies
Our Research & Clinical Trials
Multimedia

Fucoidan

Share
Share
Fucoidan

Common Names

  • Sulfated alpha-L-fucan
  • Fucoidin
  • Fucan
  • Mekabu fucoidan

Jump to:

For Patients & Caregivers

Tell your healthcare providers about any dietary supplements you’re taking, such as herbs, vitamins, minerals, and natural or home remedies. This will help them manage your care and keep you safe.

What is it?

Fucoidan is a chemical found in many species of brown seaweed. It also comes as capsules, extracts, and powder.

What is it used for?

Fucoidan is used to:

  • Boost your immune system
  • Lower inflammation (swelling)
  • Prevent blood clots
  • Reduce high blood pressure

It’s generally safe to use fucoidan in food. Talk with your healthcare providers before taking fucoidan supplements. Herbal supplements are stronger than the herbs you’d use in cooking. They can also interact with some medications and affect how they work. For more information, read the “What else do I need to know?” section below.

What are the side effects?

No major side effects have been reported.

What else do I need to know?

Talk with your healthcare provider if you’re taking a blood thinner, such as warfarin (Coumadin® and Jantoven®). Fucoidan may increase your risk of bleeding.

Back to top

For Healthcare Professionals

Clinical Summary

Fucoidan is a sulfated polysaccharide found in the cell walls of many species of brown seaweed. In vitro studies show that it has antitumor, antiangiogenic (2) (3) (4) (5) (6) (7), antiviral (15) (16), antiarthritic (18), and immunomodulatory (17) effects. Fucoidan also exhibited neuroprotective (11) (12), radioprotective (13), and antiulcer (14) properties.

In animal models, fucoidan exerts anti-inflammatory effects to protect against various organ injuries (19) (20) (21) and improved inflammatory pathology of acute colitis (22). Although a high molecular weight fucoidan did not improve outcomes in mice following intracerebral hemorrhage, it is suggested that low-molecular-weight fucoidans have increased therapeutic potential and should be evaluated for this purpose (23).

In humans, dietary fucoidan modulates platelet aggregation via anti-thrombotic effects (24). In overweight or obese adults, fucoidan over 3 months decreased diastolic blood pressure and LDL cholesterol, and increased insulin secretion (25). Fucoidan also decreased pro-viral load in a small group of patients with human T-lymphotropic virus type-1-associated neurological disease (26). Fucoisan consumption for one month prior to influenza vaccination may boost post-vaccination antibody production in immune-compromised elderly (27).

Preclinical data suggest that fucoidan can help relieve cyclophosphamide-induced intestinal mucosal injury by altering gut flora, resulting in reduced inflammation (30). Oral fucoidan in a small group of volunteers improved mobilization of hematopoietic progenitor stem cells with high levels of CXCR4 expression (28). In advanced cancer patients, fucoidan coadministration enabled patients to continue chemotherapy, regulated fatigue (29),  and reduced levels of pro-inflammatory cytokines  (31).

Because fucoidan demonstrates anticoagulant (8) (9) and antithrombotic (10) activities, it may have additive effects when taken with anticoagulants. In a small study of breast cancer patients, co-administration of fucoidan with either of two hormonal therapies, letrozole or tamoxifen, was well tolerated and did not result in any clinically significant interactions  (35).

Food Sources

Several species of brown seaweed

Purported Uses
  • Immunostimulation
  • Inflammation
  • Prevent blood clots
  • Hypertension
Mechanism of Action

In vitro, a low-molecular-weight fucoidan inhibited human rheumatoid arthritis fibroblast synoviocytes and triggered apoptosis via decreased expression and secretion of MMP-1, -3, and -9, and suppression of NF-kB binding activity, p65 nuclear translocation, and IkappaB-alpha degradation (18). In animal models, fucoidan protected against liver injury via suppression of the inflammatory signaling pathway, inflammatory mediators, and inflammatory cell infiltration (20). It also reduced production of cyclooygenase-2 and NO, while increasing expression of the hepatoprotective enzyme hemeoxygenase-1 on murine liver and HepG2 cells (21). Fucoidan suppressed inflammation in an ultraviolet B-irradiated mouse model, decreasing thickness of the prickle cell layer and MMP-1 (19).

In humans, dietary fucoidan shortens lysis time of the thrombus by elevating prostacyclin secretion caused by increased H2O2 production in the blood (24). Various antitumor, antiviral and immune-modulating effects are attributed to NK cell stimulation, and downregulation of transcription factor AP-I and IGF-IR signaling (2) (3) (32). In melanoma cells, it increased lapatinib effects via ERBB3 inhibition (33). In human colorectal cells, it reduced tumor-promoting M2 macrophages and in combination with etoposide, prevented HCT116 tumorigenicity (34). Neuroprotective effects are attributed to suppression of TNF-alpha- and IFNγ-induced NO production in C6 glioma cells (11) and to antioxidative effects (12). Fucoidan inhibits metastasis by preventing adhesion of tumor cells to the extracellular matrix (4). It induced apoptosis of human T-cell leukemia virus type I that causes adult T-cell leukemia by inactivating NF-kB, which regulates antiapoptotic proteins (3). In a murine model, fucoidan suppressed angiogenesis induced by sarcoma 180 cells (5).

Contraindications

Because of its anticoagulant properties  (8) (9), fucoidan may have additive effects with anticoagulants such as warfarin and heparin.

Adverse Reactions

Diarrhea, which improved immediately after stopping fucoidan administration (26).

Herb-Drug Interactions

Anticoagulants such as warfarin and heparin: Due to its anti-thrombotic effects, fucoidan may increase bleeding risk (24).

Dosage (OneMSK Only)
References
  1. Giraux JL, Matou S, Bros A, Tapon-Bretaudiere J, Letourneur D, Fischer AM. Modulation of human endothelial cell proliferation and migration by fucoidan and heparin. Eur J Cell Biol 1998; 77(4):352-359.
  2. Maruyama H, Tamauchi H, Hashimoto M, Nakano T. Antitumor activity and immune response of Mekabu fucoidan extracted from Sporophyll of Undaria pinnatifida. In Vivo 2003; 17(3):245-249.
  3. Haneji K, Matsuda T, Tomita M et al. Fucoidan extracted from Cladosiphon okamuranus tokida induces apoptosis of human T-cell leukemia virus type 1-infected T-cell lines and primary adult T-cell leukemia cells. Nutr Cancer 2005; 52(2):189-201.
  4. Liu JM, Bignon J, Haroun-Bouhedja F et al. Inhibitory effect of fucoidan on the adhesion of adenocarcinoma cells to fibronectin. Anticancer Res 2005; 25(3B):2129-2133.
  5. Koyanagi S, Tanigawa N, Nakagawa H, Soeda S, Shimeno H. Oversulfation of fucoidan enhances its anti-angiogenic and antitumor activities. Biochem Pharmacol 2003; 65(2):173-179.
  6. Alekseyenko TV, Zhanayeva SY, Venediktova AA, et al. Antitumor and antimetastatic activity fucoidan, a sulfated polysaccharide isolated from the Okhotsk Sea Fucus evanescens brown alga. Bull Exp Biol Med. 2007 Jun;143(6):730-2.
  7. Nagamine T, Hayakawa K, Kusakabe T, et al. Inhibitory effect of fucoidan on Huh7 hepatoma cells through downregulation of CXCL12. Nutr Cancer. 2009;61(3):340-7.
  8. Colliec S, Fischer AM, Tapon-Bretaudiere J, et al. Anticoagulant properties of a fucoïdan fraction. Thromb Res. 1991 Oct 15;64(2):143-54.
  9. Irhimeh MR, Fitton JH, Lowenthal RM. Pilot clinical study to evaluate the anticoagulant activity of fucoidan. Blood Coagul Fibrinolysis. 2009;20: 607-610.
  10. Church FC, Meade JB, Treanor RE, Whinna HC. Antithrombin activity of fucoidan. The interaction of fucoidan with heparin cofactor II, antithrombin III, and thrombin. J Biol Chem. 1989 Feb 25;264(6):3618-23.
  11. Do H, Pyo S, Sohn EH. Suppression of iNOS expression by fucoidan is mediated by regulation of p38 MAPK, JAK/STAT, AP-1 and IRF-1, and depends on up-regulation of scavenger receptor B1 expression in TNF-alpha- and IFN-gamma-stimulated C6 glioma cells. J Nutr Biochem. 2010 Aug;21(8):671-9.
  12. Luo D, Zhang Q, Wang H, et al. Fucoidan protects against dopaminergic neuron death in vivo and in vitro. Eur J Pharmacol. 2009 Sep 1;617(1-3):33-40.
  13. Byon YY, Kim MH, Yoo ES, et al. Radioprotective effects of fucoidan on bone marrow cells: improvement of the cell survival and immunoreactivity. J Vet Sci. 2008 Dec;9(4):359-65.
  14. Choi JI, Raghavendran HR, Sung NY, et al. Effect of fucoidan on aspirin-induced stomach ulceration in rats. Chem Biol Interact. 2010 Jan 5;183(1):249-54.
  15. Lee JB, Hayashi K, Hashimoto M, Nakano T, Hayashi T. Novel antiviral fucoidan from sporophyll of Undaria pinnatifida (Mekabu). Chem Pharm Bull (Tokyo). 2004 Sep;52(9):1091-4.
  16. Hayashi K, Nakano T, Hashimoto M, Kanekiyo K, Hayashi T. Defensive effects of a fucoidan from brown alga Undaria pinnatifida against herpes simplex virus infection. Int Immunopharmacol. 2008 Jan;8(1):109-16.
  17. Raghavendran HR, Srinivasan P, Rekha S. Immunomodulatory activity of fucoidan against aspirin-induced gastric mucosal damage in rats. Int Immunopharmacol. 2011 Feb;11(2):157-63.
  18. Shu Z, Shi X, Nie D, et al. Low-Molecular-Weight Fucoidan Inhibits the Viability and Invasiveness and Triggers Apoptosis in IL-1beta-Treated Human Rheumatoid Arthritis Fibroblast Synoviocytes. Inflammation. Oct 2015;38(5):1777-1786.
  19. Maruyama H, Tamauchi H, Kawakami F, et al. Suppressive Effect of Dietary Fucoidan on Proinflammatory Immune Response and MMP-1 Expression in UVB-Irradiated Mouse Skin. Planta Med. Oct 2015;81(15):1370-1374.
  20. Li XJ, Ye QF. Fucoidan reduces inflammatory response in a rat model of hepatic ischemia-reperfusion injury. Can J Physiol Pharmacol. Nov 2015;93(11):999-1005.
  21. Lim JD, Lee SR, Kim T, et al. Fucoidan from Fucus vesiculosus protects against alcohol-induced liver damage by modulating inflammatory mediators in mice and HepG2 cells. Mar Drugs. Feb 2015;13(2):1051-1067.
  22. Lean QY, Eri RD, Fitton JH, et al. Fucoidan Extracts Ameliorate Acute Colitis. PLoS One. 2015;10(6):e0128453.
  23. Burchell SR, Iniaghe LO, Zhang JH, et al. Fucoidan from Fucus vesiculosus Fails to Improve Outcomes Following Intracerebral Hemorrhage in Mice. Acta Neurochir Suppl. 2016;121:191-198.
  24. Ren R, Azuma Y, Ojima T, et al. Modulation of platelet aggregation-related eicosanoid production by dietary F-fucoidan from brown alga Laminaria japonica in human subjects. Br J Nutr. Sep 14 2013;110(5):880-890.
  25. Hernandez-Corona DM, Martinez-Abundis E, Gonzalez-Ortiz M. Effect of fucoidan administration on insulin secretion and insulin resistance in overweight or obese adults. J Med Food. Jul 2014;17(7):830-832.
  26. Araya N, Takahashi K, Sato T, et al. Fucoidan therapy decreases the proviral load in patients with human T-lymphotropic virus type-1-associated neurological disease. Antivir Ther. 2011;16(1):89-98.
  27. Negishi H, Mori M, Mori H, et al. Supplementation of elderly Japanese men and women with fucoidan from seaweed increases immune responses to seasonal influenza vaccination. J Nutr. Nov 2013;143(11):1794-1798.
  28. Irhimeh MR, Fitton JH, Lowenthal RM. Fucoidan ingestion increases the expression of CXCR4 on human CD34+ cells. Exp Hematol. Jun 2007;35(6):989-994.
  29. Ikeguchi M, Yamamoto M, Arai Y, et al. Fucoidan reduces the toxicities of chemotherapy for patients with unresectable advanced or recurrent colorectal cancer. Oncol Lett. Mar 2011;2(2):319-322.
  30. Shi H, Chang Y, Gao Y, et al. Dietary fucoidan of Acaudina molpadioides alters gut microbiota and mitigates intestinal mucosal injury induced by cyclophosphamide. Food Funct. 2017 Sep 20;8(9):3383-3393.
  31. Takahashi H, Kawaguchi M, Kitamura K, et al. An Exploratory Study on the Anti-inflammatory Effects of Fucoidan in Relation to Quality of Life in Advanced Cancer Patients. Integr Cancer Ther. Jun 2018;17(2):282-291.
  32. Kim IH, Nam TJ. Fucoidan downregulates insulin-like growth factor-I receptor levels in HT-29 human colon cancer cells. Oncol Rep. 2018 Mar;39(3):1516-1522.
  33. Thakur V, Lu J, Roscilli G, et al. The natural compound fucoidan from New Zealand Undaria pinnatifida synergizes with the ERBB inhibitor lapatinib enhancing melanoma growth inhibition. Oncotarget. 2017 Mar 14;8(11):17887-17896.
  34. Chen LM, Liu PY, Chen YA, Tseng HY, Shen PC, Hwang PA, Hsu HL. Oligo-Fucoidan prevents IL-6 and CCL2 production and cooperates with p53 to suppress ATM signaling and tumor progression. Sci Rep. 2017 Sep 19;7(1):11864.
  35. Tocaciu S, Oliver LJ, Lowenthal RM, et al. The Effect of Undaria pinnatifida Fucoidan on the Pharmacokinetics of Letrozole and Tamoxifen in Patients With Breast Cancer. Integr Cancer Ther. Mar 2018;17(1):99-105.
Back to top
Back to top
Email your questions and comments to [email protected].

Last Updated